Frederik A. Verburg and Andreas Pfestroff are at the University Hospital Marburg, Department of Nuclear Medicine, Baldingerstraβe, 35043 Marburg, Germany.
Checking for direct PDF access through Ovid
The speed with which PSMA PET-CT has been adopted for prostate cancer imaging is unprecedented. This technique's clinical value in recurrent disease is uncontested, but its role in initial staging is unclear. Two studies now provide important data on the value of PSMA PET-CT at this management stage.Refers to van Leeuwen, P. J. et al. Prospective evaluation of 68Gallium-PSMA positron emission tomography/computerized tomography for preoperative lymph node staging in prostate cancer. BJU Int.http://dx.doi.org/10.1111/bju.13540 (2016) | Rhee, H. et al. PSMA PET may improve the diagnostic accuracy of mpMRI in localised prostate cancer as confirmed by whole-mount histopathology.J. Urol.http://dx.doi.org/10.1016/j.juro.2016.02.3000 (2016)